GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Interest Expense

IDGXF (Integrated Diagnostics Holdings) Interest Expense : $-1.69 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Integrated Diagnostics Holdings's interest expense for the three months ended in Jun. 2024 was $ -0.83 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $-1.69 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Integrated Diagnostics Holdings's Operating Income for the three months ended in Jun. 2024 was $ 4.50 Mil. Integrated Diagnostics Holdings's Interest Expense for the three months ended in Jun. 2024 was $ -0.83 Mil. Integrated Diagnostics Holdings's Interest Coverage for the quarter that ended in Jun. 2024 was 5.39. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Integrated Diagnostics Holdings Interest Expense Historical Data

The historical data trend for Integrated Diagnostics Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Interest Expense Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.79 -4.32 -6.24 -4.98 -4.58

Integrated Diagnostics Holdings Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -0.98 - -0.86 -0.83

Integrated Diagnostics Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings  (OTCPK:IDGXF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Integrated Diagnostics Holdings's Interest Expense for the three months ended in Jun. 2024 was $-0.83 Mil. Its Operating Income for the three months ended in Jun. 2024 was $4.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was $21.24 Mil.

Integrated Diagnostics Holdings's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*4.497/-0.834
=5.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Integrated Diagnostics Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Interest Expense
Comparable Companies
LSE:DXRX LSE:AGL LSE:LLAI LSE:PRM LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
IDHCl:UK IDHC:UK
Address
IFC 5, Saint Helier, JEY, JE1 1ST
Website
https://www.idhcorp.com
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.